Reshma Kewalramani
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,600,000 | $21,144,261 |
| 2024 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,541,154 | $21,538,668 |
| 2023 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,500,000 | $20,594,441 |
| 2022 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,396,154 | $15,864,497 |
| 2021 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,221,923 | $15,198,856 |
| 2020 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $1,097,308 | $9,111,359 |
| 2019 | Vertex Pharmaceuticals Inc / Ma (VRTX) | CEO and President | $702,308 | $6,816,936 |
Executive changes
Earnings-call appearances
-
Vertex Pharmaceuticals Q2 2026 Conference Call2026-08-03
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Acquisition of Crinetics Pharmaceuticals Conference Call2026-07-06
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Bernstein’s 42nd Annual Strategic Decisions Conference (SDC)2026-05-29
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2026 Earnings Call2026-05-04
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Barclays 28th Annual Global Healthcare Conference2026-03-11
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2025 Earnings Call2026-02-12
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2025 Earnings Call2025-11-03
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2025 Earnings Call2025-08-04
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2025 Earnings Call2025-05-05
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2024 Earnings Call2025-02-10
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2024 Earnings Call2024-11-04
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2024 Earnings Call2024-08-01
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2024 Earnings Call2024-05-06
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2023 Earnings Call2024-02-05
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2023 Earnings Call2023-11-06
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2023 Earnings Call2023-08-01
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2023 Earnings Call2023-05-01
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2022 Earnings Call2023-02-07
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2022 Earnings Call2022-10-27
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2022 Earnings Call2022-08-04
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2022 Earnings Call2022-05-05
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2021 Earnings Call2022-01-26
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2021 Earnings Call2021-11-02
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2021 Earnings Call2021-07-29
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2021 Earnings Call2021-04-29
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q4 FY2020 Earnings Call2021-02-01
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q3 FY2020 Earnings Call2020-10-29
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q2 FY2020 Earnings Call2020-07-30
Vertex Pharmaceuticals Inc / Ma (VRTX)
-
Vertex Pharmaceuticals Inc / Ma Q1 FY2020 Earnings Call2020-04-29
Vertex Pharmaceuticals Inc / Ma (VRTX)